Filing Details
- Accession Number:
- 0001181431-13-056950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-05 17:36:50
- Reporting Period:
- 2013-11-01
- Filing Date:
- 2013-11-05
- Accepted Time:
- 2013-11-05 17:36:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
860730 | Hca Holdings Inc. | HCA | Services-General Medical & Surgical Hospitals, Nec (8062) | 273865930 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1392780 | Hercules Holding Ii, Llc | C/O Kohlberg Kravis &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Disposition | 2013-11-01 | 29,580,887 | $46.92 | 139,574,819 | No | 4 | S | Direct | |
Common Stock, Par Value $0.01 Per Share | Disposition | 2013-11-01 | 10,656,436 | $46.92 | 128,918,383 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- In connection with the secondary offering (the "Secondary Offering") of common stock, par value $0.01 per share (the "Common Stock"), of HCA Holdings, Inc. (the "Company") by certain selling shareholders to Goldman, Sachs & Co. pursuant to an underwriting agreement (the "Underwriting Agreement") and final prospectus supplement, each dated October 29, 2013, Hercules Holding II, LLC ("Hercules"), as a selling shareholder, sold 29,580,887 shares of Common Stock of the Company. The price reported represents the $47.00 secondary public offering price per share of Common Stock, less the underwriting discount of $0.08 per share of Common Stock. The Secondary Offering closed on November 1, 2013.
- In connection with the repurchase of Common Stock from Hercules by the Company (the "Share Repurchase") pursuant to a share repurchase agreement between the Company and Hercules, Hercules sold 10,656,436 shares of Common Stock of the Company at $46.92 per share. The Share Repurchase closed on November 1, 2013.
- Following the sale of shares of Common Stock reported herein, Hercules directly holds 128,918,383 shares of Common Stock. The membership interests of Hercules Holding II, LLC are held by a private investor group, including affiliates of Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co. L.P. and Company founder Dr. Thomas F. Frist, Jr. Each of such persons disclaims membership in any such group and each of such persons other than Hercules disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.